EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Calmodulin and Amyloid Beta as Coregulators of Critical Events during the Onset and Progression of Alzheimer’s Disease

Danton H O'Day iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Danton H O'Day. Beteiligte Einrichtung: Cell and Systems Biology, University of Toronto, Toronto, ON M5S 3G5, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calmodulin (CaM) and a diversity of CaM-binding proteins (CaMBPs) are involved in the onset and progression of Alzheimer’s disease (AD). In the amyloidogenic pathway, AβPP1, BACE1 and PSEN-1 are all calcium-dependent CaMBPs as are the risk factor proteins BIN1 and TREM2. Ca2+/CaM-dependent protein kinase II (CaMKII) and calcineurin (CaN) are classic CaMBPs involved in memory and plasticity, two events impacted by AD. Coupled with these events is the production of amyloid beta monomers (Aβ) and oligomers (Aβo). The recent revelations that Aβ and Aβo each bind to both CaM and to a host of Aβ receptors that are also CaMBPs adds a new level of complexity to our understanding of the onset and progression of AD. Multiple Aβ receptors that are proven CaMBPs (e.g., NMDAR, PMCA) are involved in calcium homeostasis an early event in AD and other neurodegenerative diseases. Other CaMBPs that are Aβ receptors are AD risk factors while still others are involved in the amyloidogenic pathway. Aβ binding to receptors not only serves to control CaM’s ability to regulate critical proteins, but it is also implicated in Aβ turnover. The complexity of the Aβ/CaM/CaMBP interactions is analyzed using two events: Aβ generation and NMDAR function. The interactions between Aβ, CaM and CaMBPs reveals a new level of complexity to critical events associated with the onset and progression of AD and may help to explain the failure to develop successful therapeutic treatments for the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansAmyloid beta-PeptidesCalmodulinAmyloid Precursor Protein SecretasesCalciumAspartic Acid Endopeptidases

Stichwörter der Autor:innen

Alzheimer’s diseaseNMDARamyloid beta receptorsamyloid pathwaycalcium regulationcalmodulin binding proteinsneurodegeneration

Substanzen

Amyloid beta-PeptidesCalmodulinAmyloid Precursor Protein SecretasesCalciumAspartic Acid Endopeptidases

Autor:innen und Institutionen

  • Cell and Systems Biology, University of Toronto, Toronto, ON M5S 3G5, Canada.
  • Department of Biology, University of Toronto Mississauga, Mississauga, ON L5L 1C6, Canada.

ORCID-Profile: Danton H O'Day

Zitieren

APA

O'Day, D. H. (2023). Calmodulin and Amyloid Beta as Coregulators of Critical Events during the Onset and Progression of Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021393

Vancouver

O'Day DH. Calmodulin and Amyloid Beta as Coregulators of Critical Events during the Onset and Progression of Alzheimer’s Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021393

BibTeX
@article{ODay2023,
  author = {O'Day, Danton H},
  title = {Calmodulin and Amyloid Beta as Coregulators of Critical Events during the Onset and Progression of Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021393}
}
Kostenlos starten →